DUCHEMBIO CO, LTDDUCHEMBIO CO, LTDDUCHEMBIO CO, LTD

DUCHEMBIO CO, LTD

No trades
See on Supercharts
Market capitalization
‪258.37 B‬KRW
‪4.00 B‬KRW
‪34.70 B‬KRW
‪10.21 M‬
Beta (1Y)
1.48

About DUCHEMBIO CO, LTD


CEO
Jong-Woo Kim
Headquarters
Seoul
Founded
2002
ISIN
KR7176750008
FIGI
BBG007SVGCM7
DuChemBIO Co., Ltd. engages in the manufacture and sale of radiation medicines. It operates through the following divisions: Radiation, Equipment Sharing, and Contrast Medium. The Radiation division provides analyzing equipment for several diseases. The Equipment Sharing division offers machine sharing with hospitals. The Contrast Medium division provides computerized tomography contrast mediums. The company was founded on November 6, 2002 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DUCHEMBIO CO, LTD stocks are traded under the ticker 176750.
Yes, you can track DUCHEMBIO CO, LTD financials in yearly and quarterly reports right on TradingView.
No, 176750 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 133.00 employees. See our rating of the largest employees — is DUCHEMBIO CO, LTD on this list?
Like other stocks, 176750 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DUCHEMBIO CO, LTD stock right from TradingView charts — choose your broker and connect to your account.